Inhibition of lapatinib-induced kinome reprogramming in ERBB2-positive breast cancer by targeting BET family bromodomains

T. J. Stuhlmiller, S. M. Miller, J. S. Zawistowski, K. Nakamura, A. S. Beltran, J. S. Duncan, S. P. Angus, K. A. L. Collins, D. A. Granger, R. A. Reuther, L. M. Graves, S. M. Gomez, P-F Kuan, J. S. Parker, X. Chen, N. Sciaky, L. A. Carey, H. S. Earp, J. Jin, G. L. Johnson

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalCell Reports
Volume11
DOIs
StatePublished - Jan 1 2015

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this